Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors

• Jiang Li,
• Min Zhao,
• Lei Chen,
• Qin Zhang,
• Gang Wang,
• Junnian Zheng,
• Lin Fang,
• Lunxiu Qin,
• Changqing Su,
• Yinghan Su,
• Weidan Ji,
• Lin Ang,
• Yuan Sen

Affiliations

Jiang Li

Palo Alto Medical Foundation Research Institute, Palo Alto, California, USA

Min Zhao

Shanghai Drug Abuse Treatment Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Lei Chen

Vitral Statistics, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China

Qin Zhang

Department of Emergency Medicine, West China Hospital, Sichuan University, Chengdu, China

Gang Wang

1 Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China

Junnian Zheng

Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China

Lin Fang

Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China

Lunxiu Qin

Liver Cancer Institute and Zhongshan Hospital, Institutes of Biomedical Science, Fudan University, Shanghai, China

Changqing Su

Laboratory of Viral & Gene Therapy, Eastern Hepatobiliary Surgical Hospital, The Second Military Medical University, Shanghai, China

Yinghan Su

Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Fudan University, Shanghai 200040, China

Weidan Ji

National Center for Liver Cancer (NCLC), Navy Military Medical University, Shanghai 201805, China

Lin Ang

Department of Pathology, Second People`s Hospital of Hefei, Hefei 230011, Anhui, China

Yuan Sen

Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy & Cancer Institute, Xuzhou Medical University, Xuzhou 221002, Jiangsu, China